These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19852036)

  • 1. The Journal of Pathology 2008 Jeremy Jass Prize for Research Excellence in Pathology.
    Hall PA; Poulsom R; Coates PJ; Du MQ; Hogendoorn PC; Jones LJ; Ladanyi M; Murray GI; Niedobitek G
    J Pathol; 2009 Dec; 219(4):393-5. PubMed ID: 19852036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epigenetic inactivation of microRNA genes in mammary carcinoma].
    Lehmann U; Hasemeier B; Römermann D; Müller M; Länger F; Kreipe H
    Verh Dtsch Ges Pathol; 2007; 91():214-20. PubMed ID: 18314617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline mutation of microRNA-125a is associated with breast cancer.
    Li W; Duan R; Kooy F; Sherman SL; Zhou W; Jin P
    J Med Genet; 2009 May; 46(5):358-60. PubMed ID: 19411564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jeremy Jass Prize for Research Excellence in Pathology 2017.
    J Pathol; 2019 Feb; 247(2):279. PubMed ID: 30667066
    [No Abstract]   [Full Text] [Related]  

  • 5. [Analysis of microRNA in drug-resistant breast cancer cell line MCF-7/ADR].
    Cui XY; Guo YJ; Yao HR
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1813-5. PubMed ID: 18971180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis.
    Shen J; Ambrosone CB; DiCioccio RA; Odunsi K; Lele SB; Zhao H
    Carcinogenesis; 2008 Oct; 29(10):1963-6. PubMed ID: 18660546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.
    Qian B; Katsaros D; Lu L; Preti M; Durando A; Arisio R; Mu L; Yu H
    Breast Cancer Res Treat; 2009 Sep; 117(1):131-40. PubMed ID: 18932017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA involvement in the pathogenesis and management of breast cancer.
    Khoshnaw SM; Green AR; Powe DG; Ellis IO
    J Clin Pathol; 2009 May; 62(5):422-8. PubMed ID: 19398594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer.
    Iorio MV; Casalini P; Tagliabue E; Ménard S; Croce CM
    Eur J Cancer; 2008 Dec; 44(18):2753-9. PubMed ID: 19022662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein.
    Fazi F; Racanicchi S; Zardo G; Starnes LM; Mancini M; Travaglini L; Diverio D; Ammatuna E; Cimino G; Lo-Coco F; Grignani F; Nervi C
    Cancer Cell; 2007 Nov; 12(5):457-66. PubMed ID: 17996649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
    Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
    Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis.
    Veeck J; Geisler C; Noetzel E; Alkaya S; Hartmann A; Knüchel R; Dahl E
    Carcinogenesis; 2008 May; 29(5):991-8. PubMed ID: 18356147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prize awarded by the national union of medical publishers and health professions to the Journal de Radiologie].
    Schnitter C
    J Radiol; 2000 Nov; 81(11):1658. PubMed ID: 11104985
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioluminescence-based detection of microRNA, miR21 in breast cancer cells.
    Cissell KA; Rahimi Y; Shrestha S; Hunt EA; Deo SK
    Anal Chem; 2008 Apr; 80(7):2319-25. PubMed ID: 18302417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples.
    He C; Xiong J; Xu X; Lu W; Liu L; Xiao D; Wang D
    Biochem Biophys Res Commun; 2009 Oct; 388(1):35-40. PubMed ID: 19632201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA epigenetic alterations: predicting biomarkers and therapeutic targets in human diseases.
    Wang Y; Liang Y; Lu Q
    Clin Genet; 2008 Oct; 74(4):307-15. PubMed ID: 18713257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant epigenetic reprogramming of imprinted microRNA-127 and Rtl1 in cloned mouse embryos.
    Cui XS; Zhang DX; Ko YG; Kim NH
    Biochem Biophys Res Commun; 2009 Feb; 379(2):390-4. PubMed ID: 19126398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A repressive epigenetic domino effect confers susceptibility to breast epithelial cell transformation: implications for predicting breast cancer risk.
    Bistulfi G; Pozzi S; Ren M; Rossetti S; Sacchi N
    Cancer Res; 2006 Nov; 66(21):10308-14. PubMed ID: 17079450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CLCA2 tumour suppressor gene in 1p31 is epigenetically regulated in breast cancer.
    Li X; Cowell JK; Sossey-Alaoui K
    Oncogene; 2004 Feb; 23(7):1474-80. PubMed ID: 14973555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.